Cormorant Asset Management

Praxis Precision Medicines

Boston

The era of genetic neuroscience has arrived

Neurona Therapeutics

South San Francisco

Neurona Therapeutics is a biotherapeutics company that focuses on developing cell-based therapies to address neurological disorders.

Stoke Therapeutics

Bedford

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.

JENAVALVE TECHNOLOGY

Irvine

JenaValve is a medical device company focused on the design and development of innovative transcatheter heart valve solutions

Artiva Biotherapeutics

San Diego

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

BiVACOR

Huntington Beach

BiVACOR designs and manufactures centrifugal heart pumps.

Element Science

San Francisco

Element Science is a San Francisco-based medical device startup focused on patient-first, lifesaving devices for heart disease; its first product is funded by Google Ventures and Third Rock Ventures, blending user-centric design with medica

AnaptysBio

San Diego

AnaptysBio is a biotechnology company that develops antibody therapeutics based on somatic hypermutation.

ADARx Pharmaceuticals

San Diego

ADARx Pharmaceuticals, Inc., a San Diego-based clinical-stage biotechnology company, develops RNA-targeting platforms and oligonucleotide delivery technologies to inhibit, degrade, or edit disease-causing mRNA, pursuing programs across gene

Dicerna Pharmaceuticals

Lexington

Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease.

REGENXBIO

Rockville

REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.